Introducing VIPER® Platform Technology

Our cutting-edge VIPER® Platform Technology delivers rapid, reliable, and affordable pathogen detection, transforming the way healthcare providers diagnose and treat infectious diseases worldwide
2025 03 26 DetactDiagnostics CasperMaas CMA9171

VIPER® is a Disruptive Platform Technology

VIPER® is an innovative platform technology that redefines infection diagnostics with unmatched speed, sensitivity, and accuracy.

Unlike traditional methods, it directly identifies viable pathogens in real-time, eliminating the delays of culture-based testing and reducing reliance on complex laboratory infrastructure.

Its advanced fluorescence-based technology enables rapid, direct pathogen detection—not a host response—allowing for faster, more targeted treatment decisions that improve patient outcomes and reduce healthcare costs.

"Powered by continuous innovation, our proprietary VIPER® Technology platform delivers highly sensitive and rapid detection, equipping healthcare professionals with the tools they need for early diagnosis and effective treatment—helping them stay ahead of infections and make informed decisions when it matters most."

Matthew Burton CTO

The Simplicity of VIPER®

2025 03 26 DetactDiagnostics CasperMaas CMA9088
Collect

No Sample Prep

Near infrared (NIR) fluorescence detection minimizes matrix effects and ensures high accuracy, even in highly diluted samples
2025 03 26 DetactDiagnostics CasperMaas CMA9022
Read

Versatile Platform

VIPER® can be formulated to meet the needs of point of care and high throughput diagnostic applications
Roberto Sorin RS0 H PyByk Unsplash
Treat

Immediate Targeted Treatment

VIPER® assays provide rapid results enabling health care professionals with actionable data

The Current Diagnostics Landscape

VIPER®
PCR
Growth Culture
Lateral Flow
Direct Pathogen Detection
Viable Pathogen Detection
No Sample Prep
Fast (<60s)
Point-of-Care
Affordable
User Friendly
Scalable
VIPER® Applications
0
In development
DeNIRO® mini analysis time
0
Seconds
Tests per DeNIRO® mini
0+
Per day

Patented,Patent,Copyright,Law,Business,Technology,Concept.
IP Portfolio

Detact Diagnostics holds 50+ patent rights protecting its cutting-edge VIPER® technology. This strong IP foundation secures our leadership in next-generation diagnostics and ensures the highest standards of accuracy and reliability
DFSS Gears
Solid Design Process

Detact Diagnostics applies Design for Six Sigma (DFSS) principles, tools, methods and best practices to the design, characterization and optimization of IVD assay reagents and protocols to enable a solid development process